Embargo Policy for the AACR-NCI-EORTC Molecular Targets Meeting
SAN FRANCISCO – The American Association for Cancer Research announces the following embargo policy for the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, to be held in San Francisco Nov. 12-16, 2011.
The policy states:
Due to the high volume of sensitive fiduciary data in the abstracts for the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, the embargo for all abstracts will lift at 10:00 a.m. PT, Sat., Nov. 12, 2011, when they are available to registrants in San Francisco and posted online.
Some abstracts have been blocked and will not appear in the program or online on Nov. 12. These abstracts will break embargo at their meeting presentations and will be available online at http://mct.aacrjournals.org shortly after the presentation.
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 laboratory, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards to young investigators, and it also funds cutting-edge research projects conducted by senior researchers. The AACR has numerous fruitful collaborations with organizations and foundations in the U.S. and abroad, and functions as the Scientific Partner of Stand Up To Cancer, a charitable initiative that supports groundbreaking research aimed at getting new cancer treatments to patients in an accelerated time frame. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care, and Educational Workshops are held for the training of young cancer investigators. The AACR publishes seven major peer-reviewed journals: Cancer Discovery; Cancer Research; Clinical Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Prevention Research. In 2010, AACR journals received 20 percent of the total number of citations given to oncology journals. The AACR also publishes Cancer Today, a magazine for cancer patients, survivors and their caregivers, which provides practical knowledge and new hope for cancer survivors. A major goal of the AACR is to educate the general public and policymakers about the value of cancer research in improving public health, the vital importance of increases in sustained funding for cancer research and biomedical science, and the need for national policies that foster innovation and the acceleration of progress against the 200 diseases we call cancer.